Ibuprofen Lysine Wrafton Laboratories (Ibuprofen Lysine)

Ibuprofen lysine non‑selectively inhibits the cyclooxygenase enzymes COX‑1 and COX‑2. By blocking these enzymes, it reduces the synthesis of prostaglandins, which are mediators of pain, fever, and inflammation. The lowered prostaglandin levels result in decreased sensation of pain, reduced fever, and diminished inflammatory swelling.

The appropriate dose of ibuprofen lysine is determined by the prescribing healthcare professional based on the individual’s age, weight, condition being treated, and other medical factors. Patients should follow the prescriber’s instructions and the product labeling without self‑adjusting the amount.

Safety data for ibuprofen lysine in pregnancy and lactation are limited. It should only be used during pregnancy or while breastfeeding if the potential benefit justifies the possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or nursing should discuss use with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Ibuprofen lysine is a salt form of ibuprofen that dissolves more rapidly, potentially offering faster onset of pain relief compared with standard ibuprofen tablets. Both deliver the same active moiety and share similar efficacy and safety profiles, but the lysine salt may be preferred when quicker absorption is desired.

Ibuprofen lysine tablets should be stored at ambient temperature, below 25 °C, in their original packaging. Protect them from moisture, direct sunlight, and excessive heat to maintain product stability and potency throughout its shelf life.

Ibuprofen lysine is taken orally, usually with a glass of water. It can be taken with or without food, although taking it with food may lessen mild gastrointestinal discomfort. Patients should swallow the tablet whole and avoid crushing or chewing unless specifically instructed by a healthcare professional.

Serious risks include gastrointestinal bleeding or ulceration, severe allergic reactions such as anaphylaxis, and kidney injury, especially in individuals with pre‑existing renal disease or dehydration. Patients should seek immediate medical attention if they notice signs of bleeding, severe rash, swelling, or sudden loss of kidney function.

Ibuprofen lysine should be avoided by individuals with known hypersensitivity to ibuprofen or other NSAIDs, active gastrointestinal ulcers or bleeding, severe heart failure, uncontrolled hypertension, and those in the third trimester of pregnancy. It is also contraindicated in patients taking certain anticoagulants or other drugs that markedly increase bleeding risk.